Outset Medical Inc (NASDAQ:OM) has a beta value of 2.04 and has seen 3.88 million shares traded in the recent trading session. The OM stock price is -307.14% off its 52-week high price of $5.70 and 68.57% above the 52-week low of $0.44. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.49 million shares traded. The 3-month trading volume is 762.56K shares.

The consensus among analysts is that Outset Medical Inc (OM) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 2 out of 8 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.41.

Outset Medical Inc (NASDAQ:OM) trade information

Sporting 0.36% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OM stock price touched $1.40 or saw a rise of 16.67%. Year-to-date, Outset Medical Inc shares have moved 26.58%, while the 5-day performance has seen it change 23.25%. Over the past 30 days, the shares of Outset Medical Inc (NASDAQ:OM) have changed 18.07%. Short interest in the company has seen 2.62 million shares shorted with days to cover at 3.29.

Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 53.33% from the levels at last check today. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the latest price level in today’s session is -114.29% off the targeted high while a plunge would see the stock gain -114.29% from the levels at last check today.

Outset Medical Inc (OM) estimates and forecasts

Figures show that Outset Medical Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -60.86% over the past 6 months, with this year growth rate of 30.74%, compared to 24.90% for the industry. Revenue growth from the last financial year stood is estimated to be -13.79%.

5 analysts offering their estimates for the company have set an average revenue estimate of 27.85M for the current quarter. 4 have an estimated revenue figure of 29.58M for the next ending quarter. Year-ago sales stood 30.5M and 28.17M respectively for this quarter and the next, and analysts expect sales will shrink by -8.68% for the current quarter and -13.79% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -15.08% over the past 5 years. Earnings growth for 2025 is a modest 25.83% while over the next 5 years, the company’s earnings are expected to increase by 23.80%.

OM Dividends

Outset Medical Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Outset Medical Inc (NASDAQ:OM)’s Major holders

Insiders own 2.11% of the company shares, while shares held by institutions stand at 52.16% with a share float percentage of 53.28%. Investors are also buoyed by the number of investors in a company, with Outset Medical Inc having a total of 108.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 7.7 million shares worth more than $29.63 million. As of 2024-06-30, FMR LLC held 15.1214% of shares outstanding.

The other major institutional holder is AMERIPRISE FINANCIAL INC, with the holding of over 5.2 million shares as of 2024-06-30. The firm’s total holdings are worth over $20.02 million and represent 10.2162% of shares outstanding.